Investigation of PD‑L1 expression and tislelizumab efficacy in gastroesophageal adenocarcinoma using a novel tumor and immune cell score with ventana PD-L1 (SP263) assay and combined positive score (CPS)

 POSTER   09/2020

For more information about this publication, please submit a medical information request.

Nice to see you!

For newest details on our ESMO materials in a personal video meeting, please click here!
Service